Helen L. Leavis

5.1k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Helen L. Leavis is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Helen L. Leavis has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 24 papers in Infectious Diseases and 15 papers in Molecular Biology. Recurrent topics in Helen L. Leavis's work include Immunodeficiency and Autoimmune Disorders (20 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Salivary Gland Disorders and Functions (8 papers). Helen L. Leavis is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (20 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Salivary Gland Disorders and Functions (8 papers). Helen L. Leavis collaborates with scholars based in Netherlands, Germany and United States. Helen L. Leavis's co-authors include Rob J. L. Willems, Marc J. M. Bonten, Marc JM Bonten, Janetta Top, Fernanda L. Paganelli, Willem van Schaik, Frank Schuren, Martien P. M. Caspers, Willem J. B. van Wamel and Nathan Shankar and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Helen L. Leavis

59 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A guide to immunotherapy for COVID-19

2022 191 citations Frank L. van de Veerdonk, Evangelos J. Giamarellos‐Bourboulis et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen L. Leavis Netherlands	22	1.1k	759	531	386	318	69	2.2k
Lauren Lipuma United States	11	1.3k 1.1×	1.5k 2.0×	105 0.2×	853 2.2×	628 2.0×	12	3.2k
C. A. Bruggeman Netherlands	23	637 0.6×	437 0.6×	297 0.6×	486 1.3×	955 3.0×	59	2.3k
Jakub Kwieciński United States	26	652 0.6×	769 1.0×	124 0.2×	270 0.7×	134 0.4×	47	1.6k
Efthymia Petinaki Greece	24	523 0.5×	442 0.6×	308 0.6×	110 0.3×	411 1.3×	112	1.8k
Isabelle Bekeredjian‐Ding Germany	30	459 0.4×	750 1.0×	155 0.3×	1.6k 4.0×	470 1.5×	97	3.1k
Markus Hufnagel Germany	24	599 0.5×	719 0.9×	100 0.2×	417 1.1×	480 1.5×	110	2.3k
Jing-Jou Yan Taiwan	35	664 0.6×	614 0.8×	219 0.4×	220 0.6×	759 2.4×	75	2.9k
Roberto Ghiselli Italy	33	553 0.5×	1.6k 2.2×	81 0.2×	491 1.3×	339 1.1×	115	3.4k
Soon‐Pal Suh South Korea	28	1.6k 1.4×	625 0.8×	193 0.4×	281 0.7×	1.4k 4.4×	177	3.0k
Dirk Holzinger Germany	33	752 0.7×	1.8k 2.4×	168 0.3×	1.5k 3.8×	339 1.1×	85	3.6k

Countries citing papers authored by Helen L. Leavis

Since Specialization

Citations

This map shows the geographic impact of Helen L. Leavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen L. Leavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen L. Leavis more than expected).

Fields of papers citing papers by Helen L. Leavis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen L. Leavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen L. Leavis. The network helps show where Helen L. Leavis may publish in the future.

Co-authorship network of co-authors of Helen L. Leavis

This figure shows the co-authorship network connecting the top 25 collaborators of Helen L. Leavis. A scholar is included among the top collaborators of Helen L. Leavis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen L. Leavis. Helen L. Leavis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paganelli, Fernanda L., Joris M. van Montfrans, Pauline M. Ellerbroek, et al.. (2025). Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation. Microbiome. 13(1). 12–12. 6 indexed citations

Vos, Laura M., et al.. (2025). Disseminated histoplasmosis induced hemophagocytic lymphohistiocytosis in an immunocompromised patient. Clinical Infection in Practice. 26. 100488–100488.

Juliana, Norsham, Mirjam Severs, Joris M. van Montfrans, et al.. (2025). CVID Enteropathy Is Difficult To Treat and Shows a Heterogeneous Histopathology. Journal of Clinical Immunology. 45(1). 129–129.

Leavis, Helen L., Pim A. de Jong, Sabine M. P. J. Prevaes, et al.. (2024). Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 1037–1048.e3. 2 indexed citations

Laclé, Miangela M., et al.. (2024). Paucity of gastrointestinal plasma cells in common variable immunodeficiency. Current Opinion in Allergy and Clinical Immunology. 24(6). 464–471. 4 indexed citations

Prévot, J, Isabelle Meyts, Silvia Sánchez‐Ramón, et al.. (2023). The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022). Frontiers in Immunology. 14. 1245718–1245718. 2 indexed citations

Leavis, Helen L., Paul Van Daele, Catharina M. Mulders‐Manders, et al.. (2023). Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts. Lara D. Veeken. 63(6). 1656–1663. 16 indexed citations

Juliana, Norsham, Mirjam Severs, Jacques van Montfrans, et al.. (2023). AB1468 ENTEROPATHY IN DUTCH COMMON VARIABLE IMMUNODEFICIENCY COHORT. 1962.2–1962. 1 indexed citations

Hoffman, Thijs W., et al.. (2023). Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency. SHILAP Revista de lepidopterología. 2023. 1–7.

10.

Leavis, Helen L., et al.. (2023). OP0215 IMMUNOME ANALYSIS INDICATES ROBUST INHIBITION OF PROINFLAMMATORY MEDIATORS UPON LEFLUNOMIDE-HYDROXYCHLOROQUINE COMBINATION THERAPY IN SJÖGREN'S SYNDROME: CXCR3 LIGANDS AS POTENTIAL INFLAMMATORY ENDOTYPE BIOMARKERS.. Annals of the Rheumatic Diseases. 82. 141–141.

11.

Westerlaken, Geertje H. A., Eveline M. Delemarre, Petra Moerer, et al.. (2023). Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage. The Journal of Immunology. 210(4). 389–397. 7 indexed citations

12.

Legger, G. Elizabeth, Robbert G. M. Bredius, Mariëlle van Gijn, et al.. (2023). Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort. Journal of Clinical Immunology. 43(7). 1581–1596. 9 indexed citations

13.

Veerdonk, Frank L. van de, Evangelos J. Giamarellos‐Bourboulis, Peter Pickkers, et al.. (2022). A guide to immunotherapy for COVID-19. Nature Medicine. 28(1). 39–50. 191 indexed citations breakdown →

14.

Made, Caspar I. van der, Judith Potjewijd, Huub P J Willems, et al.. (2021). Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. Journal of Allergy and Clinical Immunology. 149(1). 432–439.e4. 128 indexed citations

15.

Leavis, Helen L., Pieter van Paassen, Anna van Rhenen, et al.. (2021). Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report. Lara D. Veeken. 60(9). e326–e328. 3 indexed citations

16.

Khairoun, Meriem, et al.. (2020). Case series of three adult patients with exceptional clinical presentations of haemophagocytic lymphohistiocytosis.. The Netherlands Journal of Medicine. 78(3). 136–141. 3 indexed citations

17.

Paganelli, Fernanda L., Helen L. Leavis, Nina M. van Sorge, et al.. (2018). Group IIA-Secreted Phospholipase A ₂ in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates. Infection and Immunity. 86(8). 12 indexed citations

18.

Otten, Henny G., et al.. (2017). Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?. PubMed. 35(3). 462–470. 10 indexed citations

19.

Leavis, Helen L., Rob J. L. Willems, Willem J. B. van Wamel, et al.. (2007). Insertion Sequence–Driven Diversification Creates a Globally Dispersed Emerging Multiresistant Subspecies of E. faecium. PLoS Pathogens. 3(1). e7–e7. 163 indexed citations

20.

Leavis, Helen L., Janetta Top, Nathan Shankar, et al.. (2004). A Novel Putative Enterococcal Pathogenicity Island Linked to theespVirulence Gene ofEnterococcus faeciumand Associated with Epidemicity. Journal of Bacteriology. 186(3). 672–682. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact